Subdivision
• | 204. Medicine, Surgery, Pathology and Immunology | [X] |
| 1 | Name: | Dr. Emery N. Brown | | Institution: | Massachusetts Institute of Technology; Harvard Medical School; Massachusetts General Hospital | | Year Elected: | 2023 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Living
| | Birth Date: | 1956 | | | | | Emery N. Brown, M.D., Ph.D. was born and raised in Ocala, Florida. He attended Fessenden Elementary School, Osceola Junior High School and North Marion High School before graduating from the Phillips Exeter Academy in Exeter, New Hampshire. He spent the second semester of his senior year in Barcelona, Spain studying Spanish with the School Year Abroad Program.
Brown received his B.A. in Applied Mathematics (magna cum laude) from Harvard College. Before entering the Harvard M.D. Ph.D. Program, he spent a year studying mathematics as a Rotary Fellow at the Fourier Institute in Grenoble, France. Brown went on to earn his M.A. and Ph.D. in statistics from Harvard University and his M.D. (magna cum laude) from Harvard Medical School. He completed his internship in internal medicine at the Brigham and Women’s Hospital and his anesthesiology residency at MGH. After completing his residency in 1992, Brown joined the faculty at the MGH Department of Anesthesia and Harvard Medical School. In 2005, he also joined the faculty at MIT in the Department of Brain and Cognitive Sciences and the MIT and Harvard Health Sciences and Training Program.
Brown is presently the Edward Hood Taplin Profess of Medical Engineering and Computational Neuroscience at MIT; the Warren M. Zapol Professor of Anaesthesia at Harvard Medical School; and an anesthesiologist at MGH. He is an anesthesiologist-statistician whose research is defining the neuroscience of how anesthetics produce the states of general anesthesia. He also develops statistical methods for neuroscience data analysis.
In 2013 to 2014, Brown served on President Obama’s Brain Initiative Working Group. Currently, he serves on the Board of Trustees for the Simons Foundation and the Guggenheim Foundation.
Brown is a fellow of the American Institute for Medical and Biological Engineering, the IEEE, the American Statistical Association, the Institute of Mathematical Statistics, the American Academy of Arts and Sciences and the National Academy of Inventors. Brown is also a member of the National Academy of Medicine, the National Academy of Sciences, and the National Academy of Engineering.
Brown is the recipient of an NIH Director’s Pioneer Award, a Guggenheim Fellowship in Applied Mathematics, the American Society of Anesthesiologists Excellence in Research Award, the Dickson Prize in Science, the Swartz Prize for Theoretical and Computational Neuroscience, the Pierre Galletti Award, the Gruber Prize in Neuroscience and Doctorates of Science Honoris Causas from the University of Southern California and SUNY Downstate. | |
2 | Name: | Dr. William B. Castle | | Institution: | Harvard University | | Year Elected: | 1939 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1897 | | Death Date: | 8/9/90 | | | |
3 | Name: | Dr. Judah Folkman | | Institution: | Harvard Medical School & Children's Hospital | | Year Elected: | 1999 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1933 | | Death Date: | January 14, 2008 | | | |
4 | Name: | Dr. Francis D. Moore | | Institution: | Harvard Medical School & Brigham & Women's Hospital | | Year Elected: | 1998 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1913 | | Death Date: | November 24, 2001 | | | |
5 | Name: | Dr. David G. Nathan | | Institution: | Dana-Farber Cancer Institute & Harvard Medical School | | Year Elected: | 1999 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Living
| | Birth Date: | 1929 | | | | | David Nathan is one of the most distinguished pediatric hematologists in the country. He has spent his career at Harvard University, where he has been a professor of medicine and professor of pediatrics, and in 1985 he was appointed Pediatrician-in-Chief at Childrens Hospital in Boston. In 1995 he became President of the Dana-Farber Cancer Institute. Dr. Nathan has brought to his position scientific excellence, great integrity and a warm humanity. Among other awards he has received the National Medal of Science (1990) and the Henry Stratton Medal of the American Society of Hematology (1995). He earned his M.D. from Harvard Medical School in 1955. | |
6 | Name: | Dr. Stuart H. Orkin | | Institution: | Harvard University; Howard Hughes Medical Institute | | Year Elected: | 2017 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Living
| | Birth Date: | 1946 | | | | | Stuart Orkin has made pioneering achievements in defining the molecular basis of blood disorders and fundamental regulatory mechanisms governing the development of blood stem cells and blood lineages. His research is unmatched for its combined impact on our understanding of the genetic basis of blood diseases, the control of hematopoiesis, and the basis of the human fetal (HbF) to adult hemoglobin switch. He provided the first comprehensive molecular dissection of an inherited disorder, the thalassemia syndromes, and isolated the first regulator of blood cell development (GATA1). He identified the first disease gene (X-linked chronic granulomatous disease) through positional cloning. In the past decade, he defined how HbF is silenced in adult red cells starting with genome-wide association studies (GWAS) through to gene editing, work that forms the basis for therapeutic trials to reactivate HbF in thalassemia and sickle cell disease patients. His research is a paradigm for the application of molecular genetics to medicine. In 2018 he was the recipient of the Mecthild Esser Nemmers Prize in Medical Science, in 2020 he was awarded the King Faisal Prize in Medicine, and in 2021 he was awarded the 2021 Gruber Genetics Prize. | |
| |